HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 3, 2010, Pages

  Ma, Jie ^a,b   Altomare, Annamaria ^a,c   De La Monte, Suzanne ^a   Tong, Ming ^a   Rieder, Florian ^d   Fiocchi, Claudio ^d   Behar, Jose ^a   Shindou, Hideo ^e   Biancani, Piero ^a   Harnett, Karen M ^a  

^a BROWN UNIVERSITY   (United States)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gastroesophageal reflux; IL 8; PAF; Substance P

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; BUFFER; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; HYDROCHLORIC ACID; HYDROGEN PEROXIDE; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; NEUROKININ 1 RECEPTOR; SUBSTANCE P; SUBSTANCE P ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR; VANILLOID RECEPTOR 1; INTERLEUKIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; NONHUMAN; OXYGENATION; PH; PRIORITY JOURNAL; RABBIT; SUPERNATANT; TEMPERATURE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ESOPHAGUS; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; LEUKOCYTE; METABOLISM; MUCOSA; PHYSIOLOGY;

ANIMALS; ESOPHAGUS; GENE EXPRESSION REGULATION; HYDROCHLORIC ACID; HYDROGEN PEROXIDE; INFLAMMATION; INTERLEUKIN-1; LEUKOCYTES; MUCOUS MEMBRANE; RABBITS;

EID: 77957003631     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00160.2010     Document Type: Article

References (72)

1. Aoki Y, Nakamura M, Kodama H, Matsumoto T, Shimizu T, Noma M. A radioreceptor binding assay for platelet-activating factor (PAF) using membranes from CHO cells expressing human PAF receptor. J Immunol Methods 186: 225-231, 1995.
2. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307: 97-101, 1992.
3. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Cao W, Cheng L, Behar J, Fiocchi C, Biancani P, Harnett KM. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol 287: G1131-G1139, 2004.
6. Carney CN, Orlando RC, Powell DW, Dotson MM. Morphologic alterations in early acid-induced epithelial injury of the rabbit esophagus. Lab Invest 45: 198-208, 1981.
7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824, 1997.
8. Cheng L, Cao W, Behar J, Biancani P, Harnett KM. Inflammation induced changes in arachidonic acid metabolism in cat LES circular muscle. Am J Physiol Gastrointest Liver Physiol 288: G787-G797, 2005.
9. Cheng L, Cao W, Behar J, Fiocchi C, Biancani P, Harnett KM. Acid-induced release of platelet-activating factor by human esophageal mucosa induces inflammatory mediators in circular smooth muscle. J Pharmacol Exp Ther 319: 117-126, 2006.
10. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM. HCl-induced inflammatory mediators in cat esophageal mucosa and in- flammatory mediators in esophageal circular muscle in an in vitro model of esophagitis. Am J Physiol Gastrointest Liver Physiol 290: G1307-G1317, 2006.
11. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM. In vitro model of acute esophagitis in the cat. Am J Physiol Gastrointest Liver Physiol 289: G860-G869, 2005.
12. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. Am J Physiol Gastrointest Liver Physiol 289: G418-G428, 2005.
13. Cheng L, de la Monte S, Ma J, Hong J, Tong M, Cao W, Behar J, Biancani P, Harnett KM. HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa. Am J Physiol Gastrointest Liver Physiol 297: G135-G143, 2009.
14. De la Monte SM, Lahousse SA, Carter J, Wands JR. ATP luminescence- based motility-invasion assay. Biotechniques 33: 98-100, 102, 104 passim, 2002.
15. Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 41: 131-137, 2007.
16. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 50: 451-459, 2002.
17. Fujino K, de la Fuente SG, Takami Y, Takahashi T, Mantyh CR. Attenuation of acid induced oesophagitis in VR-1 deficient mice. Gut 55: 34-40, 2006.
18. Haines KA, Kolasinski SL, Cronstein BN, Reibman J, Gold LI, Weissmann G. Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling. J Immunol 151: 1491-1499, 1993.
19. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1-85, 1990.
20. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56: 559-564, 1994.
21. Harayama T, Shindou H, Ogasawara R, Suwabe A, Shimizu T. Identification of a novel noninflammatory biosynthetic pathway of platelet- activating factor. J Biol Chem 283: 11097-11106, 2008.
22. Harbeck RJ, Hoffman AA, Redecker S, Biundo T, Kurnick J. The isolation and functional activity of polymorphonuclear leukocytes and lymphocytes separated from whole blood on a single percoll density gradient. Clin Immunol Immunopathol 23: 682-690, 1982.
23. Holzer P, Holzer-Petsche U. Tachykinins in the gut part II roles in neural excitation, secretion and inflammation. Pharmacol Ther 73: 219-263, 1997.
24. Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology 58: 163-174, 1970.
25. Isomoto H, Nishi Y, Kanazawa Y, Shikuwa S, Mizuta Y, Inoue K, Kohno S. Immune and inflammatory responses in GERD and lansoprazole. J Clin Biochem Nutr 41: 84-91, 2007.
26. Isomoto H, Saenko VA, Kanazawa Y, Nishi Y, Ohtsuru A, Inoue K, Akazawa Y, Takeshima F, Omagari K, Miyazaki M, Mizuta Y, Murata I, Yamashita S, Kohno S. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol 99: 589-597, 2004. (Pubitemid 38607958)
27. Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, Miyazaki M, Murase K, Hayashi T, Inoue K, Murata I, Kohno S. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 98: 551-556, 2003.
28. Karnovsky MJ. Robert Feulgen Lecture 1994. Cytochemistry and reactive oxygen species: a retrospective. Histochemistry 102: 15-27, 1994.
29. Kimani G, Tonnesen MG, Henson PM. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J Immunol 140: 3161-3166, 1988.
30. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg EF Jr. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106, Suppl 1: 289-295, 1998.
31. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
32. Lanas A, Royo Y, Ortego J, Molina M, Sainz R. Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. Gastroenterology 116: 97-107, 1999.
33. Leonard EJ. Nap-1 (Il-8). Immunol Today 11: 223-224, 1990.
34. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112: 1448-1456, 1997.
35. Ma J, Harnett KM, Behar J, Biancani P, Cao W. Signaling in TRPV1- induced platelet activating factor (PAF) in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol 298: G233-G240, 2010.
36. Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 45: 1-98, 1995.
37. Mantyh CR, Pappas TN, Lapp JA, Washington MK, Neville LM, Ghilardi JR, Rogers SD, Mantyh PW, Vigna SR. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 111: 1272-1280, 1996.
38. McVey DC, Vigna SR. The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats. Peptides 22: 1439-1446, 2001.
39. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 367: 2086-2100, 2006.
40. 2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods 202: 133-141, 1997.
41. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72: 391-398, 2000.
42. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265: 659-665, 1990.
43. Naya MJ, Pereboom D, Ortego J, Alda JO, Lanas A. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. Gut 40: 175-181, 1997.
44. Nomikos TN, Iatrou C, Demopoulos CA. Acetyl-CoA:1-O-alkyl-sn-glycero-3- phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue. Eur J Biochem 270: 2992-3000, 2003.
45. Nose K, Shibanuma M, Kikuchi K, Kageyama H, Sakiyama S, Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur J Biochem 201: 99-106, 1991.
46. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 201: 167-180, 2004.
47. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am J Respir Cell Mol Biol 16: 455-463, 1997.
48. Orlando RC, Powell DW, Carney CN. Pathophysiology of acute acid injury in rabbit esophageal epithelium. J Clin Invest 68: 286-293, 1981.
49. Paterson WG, Kieffer CA, Feldman MJ, Miller DV, Morris GP. Role of platelet-activating factor in acid-induced esophageal mucosal injury. Dig Dis Sci 52: 1861-1866, 2007.
50. Perianin A, Snyderman R, Malfroy B. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. Biochem Biophys Res Commun 161: 520-524, 1989.
51. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 265: 17381-17384, 1990.
52. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419-445, 2000.
53. Schratzberger P, Reinisch N, Prodinger WM, Kahler CM, Sitte BA, Bellmann R, Fischer-Colbrie R, Winkler H, Wiedermann CJ. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 158: 3895-3901, 1997.
54. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
55. Shimizu T, Ohto T, Kita Y. Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life 58: 328-333, 2006. (Pubitemid 43880025)
56. Shindou H, Hishikawa D, Nakanishi H, Harayama T, Ishii S, Taguchi R, Shimizu T. A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase. J Biol Chem 282: 6532-6539, 2007.
57. Shindou H, Ishii S, Uozumi N, Shimizu T. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem Biophys Res Commun 271: 812-817, 2000.
58. Shute JK, Rimmer SJ, Akerman CL, Church MK, Holgate ST. Studies of cellular mechanisms for the generation of superoxide by guinea-pig eosinophils and its dissociation from granule peroxidase release. Biochem Pharmacol 40: 2013-2021, 1990.
59. Singaram C, Sengupta A, Stevens C, Spechler SJ, Goyal RK. Localization of calcitonin gene-related peptide in human esophageal Langerhans cells. Gastroenterology 100: 560-563, 1991.
60. Singaram C, Sengupta A, Sugarbaker DJ, Goyal RK. Peptidergic innervation of the human esophageal smooth muscle. Gastroenterology 101: 1256-1263, 1991.
61. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta 1254: 231-249, 1995.
62. Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang HY, Zhang X, Yu C, Hormi-Carver K, Genta RM, Spechler SJ. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 137: 1776-1784, 2009.
63. Tobey NA, Orlando RC. Mechanisms of acid injury to rabbit esophageal epithelium. Role of basolateral cell membrane acidification. Gastroenterology 101: 1220-1228, 1991.
64. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78: 1701-1706, 1986.
65. Yoshida N, Uchiyama K, Kuroda M, Sakuma K, Kokura S, Ichikawa H, Naito Y, Takemura T, Yoshikawa T, Okanoue T. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol 39: 816-822, 2004.
66. Zeilhofer HU, Schorr W. Role of interleukin-8 in neutrophil signaling. Curr Opin Hematol 7: 178-182, 2000.
67. Zhang Y, Xiang B, Li YM, Wang Y, Wang X, Wang YN, Wu LL, Yu GY. Expression and characteristics of vanilloid receptor 1 in the rabbit submandibular gland. Biochem Biophys Res Commun 345: 467-473, 2006.
68. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 110: 529-540, 1990.
69. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30: S294-301, 2002.
70. Zimmerman GA, Whatley RE, McIntyre TM, Benson DM, Prescott SM. Endothelial cells for studies of platelet-activating factor and arachidonate metabolites. Methods Enzymol 187: 520-535, 1990.
71. Zoratti EM, Sedgwick JB, Vrtis RR, Busse WW. The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils. J Allergy Clin Immunol 88: 749-758, 1991.
72. Zwahlen R, Walz A, Rot A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol 34: 27-42, 1993.